Is the price fair?
What CDNA's price assumes
CareDx, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 2.23× revenue.
2.23
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.94
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 2.94
- EV / EBIToperating margin −3.9%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $1.35B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Diagnostics & Research
Ranks #8 of 29 by Smart Score